Frontiers in Oncology Seminars
Establishing Preeminence in Translational Pediatric Oncology: Bass Center Vision 2025
Tanja Gruber, MD, PhD
Tuesday, September 1, 2020
Tanja Gruber, MD, PhD, is the Division Chief of Pediatric Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine and Director of the Bass Center for Cancer and Blood Disorders. She is a product of the University of Washington, with dual BS degrees in Biology and Biochemistry; University of Southern California, there with MD in Medicine and PhD in Immunology; and Children’s Hospital of Los Angeles for Internship and Residency in Pediatrics and then Fellowship in Hematology and Oncology. Dr. Gruber was recruited after fellowship to St. Jude Children’s Research Hospital, where she became a nationally and internationally recognized physician-scientist. At St. Jude she focused on high-risk leukemia and acute megakaryoblastic leukemia (AMKL). Her laboratory research has led to the identification of CBFA2T3-GLIS2, a novel fusion gene that confers a poor prognosis in pediatric AMKL, and a detailed view of the genomic landscape in MLLr leukemia.